DNAJA1 and neoplasm: While further experiments characterizing (1) the specific DNAJA1-mediated effects in cancer proliferation and (2) the specificity of drugs such as 116-9e are required, our studies suggest perhaps a future precision medicine approach that uses tumor DNAJA1 status to guide treatment strategy.